A phase I dose escalation and expansion trial of the next-generation oral SERD camizestrant in women with ER-positive, HER2-negative advanced breast cancer: SERENA-1 monotherapy results

E. Hamilton, Maila Dayane Capuchinho de Oliveira, Nicholas C. Turner, J. García-Corbacho, Cristina Hernándo, Eva Ciruelos, Peter Kabos, Manuel Ruíz‐Borrego, Anne Armstrong, Mehul Patel,

Annals of Oncology · 2024 · 62 citations · 19 references

DOIFull text

Open access

Concepts

References

19